Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
AUTOR(ES)
Woisetschlaeger, M
RESUMO
Transcription of the genes encoding the six viral nuclear antigens present in Epstein-Barr virus latently infected lymphocytes can be initiated from one of two promoters (Cp and Wp) mapping near the left end of the viral genome. These promoters are used in a mutually exclusive manner in clonal cell lines established from either Burkitt lymphoma tumors or in vitro infection of peripheral B lymphocytes. In this paper the role of Cp and Wp during viral latency is investigated. Cp appears to be the promoter normally employed during established latent infection. Analysis of two cell lines that use Wp revealed a deletion spanning Cp in the endogenous viral genomes, suggesting that cell lines exhibiting Wp activity harbor mutated viral genomes with a nonfunctional Cp. However, in contrast to the preferred usage of Cp exhibited by established Epstein-Barr virus-infected cell lines, Wp was shown to be exclusively utilized during the initial stages of viral infection. In addition to Wp activity, Cp usage was apparent by 6 days post-infection. A model is proposed involving B-lymphocyte differentiation-driven promoter switching during the establishment of viral latency.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=53555Documentos Relacionados
- Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.
- Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes.
- Epstein-Barr virus vectors for gene delivery to B lymphocytes.
- Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes.
- Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.